CD34 and acute myeloid leukemia: The practical clinical message of our findings is to suggest not to exceed 8.3 × 10^6 of CD34+ cells per kg in AML CR1 patients undergoing RIC allo-SCT from unrelated donors in order to try to avoid severe acute GVHD without impairing the other outcomes.